Skip to content Skip to navigation

Josh Wolfe

Josh Wolfe

Josh is Co-Founder of Lux Capital and focuses on investments in the physical and life sciences. Mr. Wolfe manages Lux's investments in Nanosys, Cambrios, Siluria and serves on the Board of Directors of Kurion, Silicon Clocks, Crystal IS and Lux Research. Before forming Lux Capital, he worked in Salomon Smith Barney's Investment Banking group, in capital markets at Merrill Lynch on its Financial Futures & Options/Government Strategy desk and at Prudential Securities in Municipal Finance. Prior to venturing into the financial world, Mr. Wolfe published cutting-edge AIDS-immunopathology research in Cell Vision and The Journal of Leukocyte Biology, leading medical-immunology journals.

295 Madison Avenue
24th Floor
New York, NY
10017
USA
view on map

http://www.luxcapital.com
info@luxcapital.com
646-475-4385